Login Register Cart 0
Generic placeholder image

Current Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 0929-8673
ISSN (Online): 1875-533X

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe Translate in Chinese
Review Article

Application of Nanoparticles for Efficient Delivery of Quercetin in Cancer Cells

Author(s): Mina Homayoonfal, Azadeh Aminianfar, Zatollah Asemi* and Bahman Yousefi*

Volume 31, Issue 9, 2024

Published on: 18 April, 2023

Page: [1107 - 1141] Pages: 35

DOI: 10.2174/0929867330666230301121611

Price: $65

conference banner
Abstract

Quercetin (Qu, 3,5,7,3’, 4’-pentahydroxyflavanone) is a natural polyphenol compound abundantly found in health food or plant-based products. In recent decades, Qu has gained significant attention in the food, cosmetic, and pharmaceutic industries owning to its wide beneficial therapeutic properties such as antioxidant, anti-inflammatory and anticancer activities. Despite the favorable roles of Qu in cancer therapy due to its numerous impacts on the cell signaling axis, its poor chemical stability and bioavailability, low aqueous solubility as well as short biological half-life have limited its clinical application. Recently, drug delivery systems based on nanotechnology have been developed to overcome such limitations and enhance the Qu biodistribution following administration. Several investigations have indicated that the nano-formulation of Qu enjoys more remarkable anticancer effects than its free form. Furthermore, incorporating Qu in various nano-delivery systems improved its sustained release and stability, extended its circulation time, enhanced its accumulation at target sites, and increased its therapeutic efficiency. The purpose of this study was to provide a comprehensive review of the anticancer properties of various Qu nano-formulation to augment their effects on different malignancies. Various targeting strategies for improving Qu delivery, including nanoliposomes, lipids, polymeric, micelle, and inorganic nanoparticle NPs, have been discussed in this review. The results of the current study illustrated that a combination of appropriate nano encapsulation approaches with tumor-oriented targeting delivery might lead to establishing QU nanoparticles that can be a promising technique for cancer treatment.

Keywords: Quercetin, cancer, nanoparticle, targeting delivery, flavonoid, apoptosis.

« Previous Next »
[1]
Seyfried, T.N.; Shelton, L.M. Cancer as a metabolic disease. Nutr. Metab., 2010, 7(1), 7.
[http://dx.doi.org/10.1186/1743-7075-7-7] [PMID: 20181022]
[2]
Jing, Z.; Du, Q.; Zhang, X.; Zhang, Y. Nanomedicines and nanomaterials for cancer therapy: Progress, challenge and perspectives. Chem. Eng. J., 2022, 446, 137147.
[http://dx.doi.org/10.1016/j.cej.2022.137147]
[3]
Sung, H.; Ferlay, J.; Siegel, R.L.; Laversanne, M.; Soerjomataram, I.; Jemal, A.; Bray, F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin., 2021, 71(3), 209-249.
[http://dx.doi.org/10.3322/caac.21660] [PMID: 33538338]
[4]
Ferlay, J.; Colombet, M.; Soerjomataram, I.; Parkin, D.M.; Piñeros, M.; Znaor, A.; Bray, F. Cancer statistics for the year 2020: An overview. Int. J. Cancer, 2021, 149(4), 778-789.
[http://dx.doi.org/10.1002/ijc.33588] [PMID: 33818764]
[5]
Ghanbari-Movahed, M.; Mondal, A.; Farzaei, M.H.; Bishayee, A. Quercetin- and rutin-based nano-formulations for cancer treatment: A systematic review of improved efficacy and molecular mechanisms. Phytomedicine, 2022, 97, 153909.
[http://dx.doi.org/10.1016/j.phymed.2021.153909] [PMID: 35092896]
[6]
Yafout, M.; Ousaid, A.; Khayati, Y.; El Otmani, I.S. Gold nanoparticles as a drug delivery system for standard chemotherapeutics: A new lead for targeted pharmacological cancer treatments. Sci. Am., 2021, 11, e00685.
[7]
Sanati, M.; Afshari, A.R.; Amini, J.; Mollazadeh, H.; Jamialahmadi, T.; Sahebkar, A. Targeting angiogenesis in gliomas: Potential role of phytochemicals. J. Funct. Foods, 2022, 96, 105192.
[http://dx.doi.org/10.1016/j.jff.2022.105192]
[8]
Chikara, S.; Nagaprashantha, L.D.; Singhal, J.; Horne, D.; Awasthi, S.; Singhal, S.S. Oxidative stress and dietary phytochemicals: Role in cancer chemoprevention and treatment. Cancer Lett., 2018, 413, 122-134.
[http://dx.doi.org/10.1016/j.canlet.2017.11.002] [PMID: 29113871]
[9]
Cragg, G.M.; Pezzuto, J.M. Natural products as a vital source for the discovery of cancer chemotherapeutic and chemopreventive agents. Med. Princ. Pract., 2016, 25(Suppl 2), 41-59.
[http://dx.doi.org/10.1159/000443404] [PMID: 26679767]
[10]
Mohapatra, P.; Singh, P.; Singh, D.; Sahoo, S.; Sahoo, S.K. Phytochemical based nanomedicine: A panacea for cancer treatment, present status and future prospective. OpenNano, 2022, 7, 100055.
[11]
Hashemi Goradel, N.; Ghiyami-Hour, F.; Jahangiri, S.; Negahdari, B.; Sahebkar, A.; Masoudifar, A.; Mirzaei, H. Nanoparticles as new tools for inhibition of cancer angiogenesis. J. Cell. Physiol., 2018, 233(4), 2902-2910.
[http://dx.doi.org/10.1002/jcp.26029] [PMID: 28543172]
[12]
Schroeder, A.; Heller, D.A.; Winslow, M.M.; Dahlman, J.E.; Pratt, G.W.; Langer, R.; Jacks, T.; Anderson, D.G. Treating metastatic cancer with nanotechnology. Nat. Rev. Cancer, 2012, 12(1), 39-50.
[http://dx.doi.org/10.1038/nrc3180] [PMID: 22193407]
[13]
Davis, ME; Chen, Z; Shin, DM Nanoparticle therapeutics: An emerging treatment modality for cancer. Nat Rev Drug Discov, 2010, 7(9), 771-82.
[14]
Tran, T.T.D.; Tran, P.H.L. Nanoconjugation and encapsulation strategies for improving drug delivery and therapeutic efficacy of poorly water-soluble drugs. Pharmaceutics, 2019, 11(7), 325.
[http://dx.doi.org/10.3390/pharmaceutics11070325] [PMID: 31295947]
[15]
Jindal, A.B. The effect of particle shape on cellular interaction and drug delivery applications of micro- and nanoparticles. Int. J. Pharm., 2017, 532(1), 450-465.
[http://dx.doi.org/10.1016/j.ijpharm.2017.09.028] [PMID: 28917985]
[16]
Feng, L.; Mumper, R.J. A critical review of lipid-based nanoparticles for taxane delivery. Cancer Lett., 2013, 334(2), 157-175.
[http://dx.doi.org/10.1016/j.canlet.2012.07.006] [PMID: 22796606]
[17]
Natural product-based nanoformulations for cancer therapy: Opportunities and challenges. Seminars in cancer biology., 2021.
[18]
Zang, X.; Cheng, M.; Zhang, X.; Chen, X. Quercetin nanoformulations: A promising strategy for tumor therapy. Food Funct., 2021, 12(15), 6664-6681.
[http://dx.doi.org/10.1039/D1FO00851J] [PMID: 34152346]
[19]
Wang, G.; Wang, J.J.; Chen, X.L.; Du, L.; Li, F. Quercetin-loaded freeze-dried nanomicelles: Improving absorption and anti-glioma efficiency in vitro and in vivo. J. Control. Release, 2016, 235, 276-290.
[http://dx.doi.org/10.1016/j.jconrel.2016.05.045] [PMID: 27242199]
[20]
Williams, R.J.; Spencer, J.P.E.; Rice-Evans, C. Flavonoids: antioxidants or signalling molecules? Free Radic. Biol. Med., 2004, 36(7), 838-849.
[http://dx.doi.org/10.1016/j.freeradbiomed.2004.01.001] [PMID: 15019969]
[21]
Beecher, G.R. Overview of dietary flavonoids: Nomenclature, occurrence and intake. J. Nutr., 2003, 133(10), 3248S-3254S.
[http://dx.doi.org/10.1093/jn/133.10.3248S] [PMID: 14519822]
[22]
Mariani, C.; Braca, A.; Vitalini, S.; De Tommasi, N.; Visioli, F.; Fico, G. Flavonoid characterization and in vitro antioxidant activity of Aconitum anthora L. (Ranunculaceae). Phytochemistry, 2008, 69(5), 1220-1226.
[http://dx.doi.org/10.1016/j.phytochem.2007.12.009] [PMID: 18226822]
[23]
Thangasamy, T.; Sittadjody, S.; Burd, R. Chapter 27 - Quercetin: A Potential Complementary and Alternative Cancer Therapy. In: Complementary and Alternative Therapies and the Aging Population Elsvier: Amsterdam; , 2009; pp. 563-584.
[24]
Lee, T.J.; Kim, O.H.; Kim, Y.H.; Lim, J.H.; Kim, S.; Park, J.W.; Kwon, T.K. Quercetin arrests G2/M phase and induces caspase-dependent cell death in U937 cells. Cancer Lett., 2006, 240(2), 234-242.
[http://dx.doi.org/10.1016/j.canlet.2005.09.013] [PMID: 16274926]
[25]
Jeong, J.H.; An, J.Y.; Kwon, Y.T.; Rhee, J.G.; Lee, Y.J. Effects of low dose quercetin: Cancer cell-specific inhibition of cell cycle progression. J. Cell. Biochem., 2009, 106(1), 73-82.
[http://dx.doi.org/10.1002/jcb.21977] [PMID: 19009557]
[26]
Zhang, Q.; Zhao, X.H.; Wang, Z.J. Cytotoxicity of flavones and flavonols to a human esophageal squamous cell carcinoma cell line (KYSE-510) by induction of G2/M arrest and apoptosis. Toxicol. In Vitro, 2009, 23(5), 797-807.
[http://dx.doi.org/10.1016/j.tiv.2009.04.007] [PMID: 19397994]
[27]
Catanzaro, D.; Ragazzi, E.; Vianello, C.; Caparrotta, L.; Montopoli, M. Effect of quercetin on cell cycle and cyclin expression in ovarian carcinoma and osteosarcoma cell lines. Nat. Prod. Commun., 2015, 10(8), 1365-8.
[http://dx.doi.org/10.1177/1934578X1501000813]
[28]
Chou, C.C.; Yang, J.S.; Lu, H.F.; Ip, S.W.; Lo, C.; Wu, C.C.; Lin, J.P.; Tang, N.Y.; Chung, J.G.; Chou, M.J.; Teng, Y.H.; Chen, D.R. Quercetin-mediated cell cycle arrest and apoptosis involving activation of a caspase cascade through the mitochondrial pathway in human breast cancer MCF-7 cells. Arch. Pharm. Res., 2010, 33(8), 1181-1191.
[http://dx.doi.org/10.1007/s12272-010-0808-y] [PMID: 20803121]
[29]
Vidya Priyadarsini, R.; Senthil Murugan, R.; Maitreyi, S.; Ramalingam, K.; Karunagaran, D.; Nagini, S. The flavonoid quercetin induces cell cycle arrest and mitochondria-mediated apoptosis in human cervical cancer (HeLa) cells through p53 induction and NF-κB inhibition. Eur. J. Pharmacol., 2010, 649(1-3), 84-91.
[http://dx.doi.org/10.1016/j.ejphar.2010.09.020] [PMID: 20858478]
[30]
Hisaka, T.; Sakai, H.; Sato, T.; Goto, Y.; Nomura, Y.; Fukutomi, S.; Fujita, F.; Mizobe, T.; Nakashima, O.; Tanigawa, M.; Naito, Y.; Akiba, J.; Ogasawara, S.; Nakashima, K.; Akagi, Y.; Okuda, K.; Yano, H. Quercetin suppresses proliferation of liver cancer cell lines in vitro. Anticancer Res., 2020, 40(8), 4695-4700.
[http://dx.doi.org/10.21873/anticanres.14469] [PMID: 32727794]
[31]
Al-Ghamdi, M.A.; AL-Enazy, A.; Huwait, E.A.; Albukhari, A.; Harakeh, S.; Moselhy, S.S. Enhancement of Annexin V in response to combination of epigallocatechin gallate and quercetin as a potent arrest the cell cycle of colorectal cancer. Braz. J. Biol., 2023, 83, e248746.
[http://dx.doi.org/10.1590/1519-6984.248746] [PMID: 34495165]
[32]
Azizi, E.; Fouladdel, S.; Komeili Movahhed, T.; Modaresi, F.; Barzegar, E.; Ghahremani, M.H.; Ostad, S.N.; Atashpour, S. Quercetin effects on cell cycle arrest and apoptosis and doxorubicin activity in T47D cancer stem cells. Asian Pac. J. Cancer Prev., 2022, 23(12), 4145-4154.
[http://dx.doi.org/10.31557/APJCP.2022.23.12.4145] [PMID: 36579996]
[33]
Fernald, K.; Kurokawa, M. Evading apoptosis in cancer. Trends Cell Biol., 2013, 23(12), 620-633.
[http://dx.doi.org/10.1016/j.tcb.2013.07.006] [PMID: 23958396]
[34]
Ghobrial, I.M.; Witzig, T.E.; Adjei, A.A. Targeting apoptosis pathways in cancer therapy. CA Cancer J. Clin., 2005, 55(3), 178-194.
[http://dx.doi.org/10.3322/canjclin.55.3.178] [PMID: 15890640]
[35]
Fulda, S.; Debatin, K-M. Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene, 2006, 25(34), 4798-4811.
[http://dx.doi.org/10.1038/sj.onc.1209608] [PMID: 16892092]
[36]
Zhang, X.A.; Zhang, S.; Yin, Q.; Zhang, J. Quercetin induces human colon cancer cells apoptosis by inhibiting the nuclear factor-kappa B Pathway. Pharmacogn. Mag., 2015, 11(42), 404-409.
[http://dx.doi.org/10.4103/0973-1296.153096] [PMID: 25829782]
[37]
Teekaraman, D.; Elayapillai, S.P.; Viswanathan, M.P.; Jagadeesan, A. Quercetin inhibits human metastatic ovarian cancer cell growth and modulates components of the intrinsic apoptotic pathway in PA-1 cell line. Chem. Biol. Interact., 2019, 300, 91-100.
[http://dx.doi.org/10.1016/j.cbi.2019.01.008] [PMID: 30639267]
[38]
Shang, H.S.; Lu, H.F.; Lee, C.H.; Chiang, H.S.; Chu, Y.L.; Chen, A.; Lin, Y.F.; Chung, J.G. Quercetin induced cell apoptosis and altered gene expression in AGS human gastric cancer cells. Environ. Toxicol., 2018, 33(11), 1168-1181.
[http://dx.doi.org/10.1002/tox.22623] [PMID: 30152185]
[39]
Psahoulia, F.H.; Drosopoulos, K.G.; Doubravska, L.; Andera, L.; Pintzas, A. Quercetin enhances TRAIL-mediated apoptosis in colon cancer cells by inducing the accumulation of death receptors in lipid rafts. Mol. Cancer Ther., 2007, 6(9), 2591-2599.
[http://dx.doi.org/10.1158/1535-7163.MCT-07-0001] [PMID: 17876056]
[40]
Yi, L.; Zongyuan, Y.; Cheng, G.; Lingyun, Z.; GuiLian, Y.; Wei, G. Quercetin enhances apoptotic effect of tumor necrosis factor related apoptosis inducing ligand (TRAIL) in ovarian cancer cells through reactive oxygen species (ROS) mediated CCAAT enhancer-binding protein homologous protein (CHOP)-death receptor 5 pathway. Cancer Sci., 2014, 105(5), 520-527.
[http://dx.doi.org/10.1111/cas.12395] [PMID: 24612139]
[41]
Jung, Y.H.; Heo, J.; Lee, Y.J.; Kwon, T.K.; Kim, Y.H. Quercetin enhances TRAIL-induced apoptosis in prostate cancer cells via increased protein stability of death receptor 5. Life Sci., 2010, 86(9-10), 351-357.
[http://dx.doi.org/10.1016/j.lfs.2010.01.008] [PMID: 20096292]
[42]
Tummala, R.; Lou, W.; Gao, A.C.; Nadiminty, N. Quercetin targets hnRNPA1 to overcome enzalutamide resistance in prostate cancer cells. Mol. Cancer Ther., 2017, 16(12), 2770-2779.
[http://dx.doi.org/10.1158/1535-7163.MCT-17-0030] [PMID: 28729398]
[43]
Wong, M.L.H.; Prawira, A.; Kaye, A.H.; Hovens, C.M. Tumour angiogenesis: Its mechanism and therapeutic implications in malignant gliomas. J. Clin. Neurosci., 2009, 16(9), 1119-1130.
[http://dx.doi.org/10.1016/j.jocn.2009.02.009] [PMID: 19556134]
[44]
Adams, R.H.; Alitalo, K. Molecular regulation of angiogenesis and lymphangiogenesis. Nat. Rev. Mol. Cell Biol., 2007, 8(6), 464-478.
[http://dx.doi.org/10.1038/nrm2183] [PMID: 17522591]
[45]
Kashyap, D.; Mittal, S.; Sak, K.; Singhal, P.; Tuli, H.S. Molecular mechanisms of action of quercetin in cancer: Recent advances. Tumour Biol., 2016, 37(10), 12927-12939.
[http://dx.doi.org/10.1007/s13277-016-5184-x] [PMID: 27448306]
[46]
Tang, S.M.; Deng, X.T.; Zhou, J.; Li, Q.P.; Ge, X.X.; Miao, L. Pharmacological basis and new insights of quercetin action in respect to its anti-cancer effects. Biomed. Pharmacother., 2020, 121, 109604.
[http://dx.doi.org/10.1016/j.biopha.2019.109604] [PMID: 31733570]
[47]
Klagsbrun, M.; Moses, M.A. Molecular angiogenesis. Chem. Biol., 1999, 6(8), R217-R224.
[http://dx.doi.org/10.1016/S1074-5521(99)80081-7] [PMID: 10421764]
[48]
Liu, Y.; Tang, Z.G.; Yang, J.Q.; Zhou, Y.; Meng, L.H.; Wang, H.; Li, C.L. Low concentration of quercetin antagonizes the invasion and angiogenesis of human glioblastoma U251 cells. OncoTargets Ther., 2017, 10, 4023-4028.
[http://dx.doi.org/10.2147/OTT.S136821] [PMID: 28860810]
[49]
Zhao, X.; Wang, Q.; Yang, S.; Chen, C.; Li, X.; Liu, J.; Zou, Z.; Cai, D. Quercetin inhibits angiogenesis by targeting calcineurin in the xenograft model of human breast cancer. Eur. J. Pharmacol., 2016, 781, 60-68.
[http://dx.doi.org/10.1016/j.ejphar.2016.03.063] [PMID: 27041643]
[50]
Pratheeshkumar, P.; Budhraja, A.; Son, Y.-O.; Wang, X.; Zhang, Z.; Ding, S. Quercetin inhibits angiogenesis mediated human prostate tumor growth by targeting VEGFR- 2 regulated AKT/mTOR/P70S6K signaling pathways. PLoS One, 2012, 7(10), e47516.
[51]
Liu, Y.; Li, C.L.; Xu, Q.Q.; Cheng, D.; Liu, K.D.; Sun, Z.Q. Quercetin inhibits invasion and angiogenesis of esophageal cancer cells. Pathol. Res. Pract., 2021, 222, 153455.
[http://dx.doi.org/10.1016/j.prp.2021.153455] [PMID: 33962176]
[52]
Kee, J.Y.; Han, Y.H.; Kim, D.S.; Mun, J.G.; Park, J.; Jeong, M.Y.; Um, J.Y.; Hong, S.H. Inhibitory effect of quercetin on colorectal lung metastasis through inducing apoptosis, and suppression of metastatic ability. Phytomedicine, 2016, 23(13), 1680-1690.
[http://dx.doi.org/10.1016/j.phymed.2016.09.011] [PMID: 27823633]
[53]
Chang, J.H.; Lai, S.L.; Chen, W.S.; Hung, W.Y.; Chow, J.M.; Hsiao, M.; Lee, W.J.; Chien, M.H. Quercetin suppresses the metastatic ability of lung cancer through inhibiting Snail-dependent Akt activation and Snail-independent ADAM9 expression pathways. Biochim. Biophys. Acta Mol. Cell Res., 2017, 1864(10), 1746-1758.
[http://dx.doi.org/10.1016/j.bbamcr.2017.06.017] [PMID: 28648644]
[54]
García-Prat, L.; Martínez-Vicente, M.; Perdiguero, E.; Ortet, L.; Rodríguez-Ubreva, J.; Rebollo, E.; Ruiz-Bonilla, V.; Gutarra, S.; Ballestar, E.; Serrano, A.L.; Sandri, M.; Muñoz-Cánoves, P. Autophagy maintains stemness by preventing senescence. Nature, 2016, 529(7584), 37-42.
[http://dx.doi.org/10.1038/nature16187] [PMID: 26738589]
[55]
Mulcahy Levy, J.M.; Thorburn, A. Autophagy in cancer: Moving from understanding mechanism to improving therapy responses in patients. Cell Death Differ., 2020, 27(3), 843-857.
[http://dx.doi.org/10.1038/s41418-019-0474-7] [PMID: 31836831]
[56]
Sui, X.; Chen, R.; Wang, Z.; Huang, Z.; Kong, N.; Zhang, M. Autophagy and chemotherapy resistance: A promising therapeutic target for cancer treatment. Cell Death Dis, 2013, 4(10), 838.
[http://dx.doi.org/10.1038/cddis.2013.350]
[57]
Marinković, M.; Šprung, M.; Buljubašić, M.; Novak, I. Autophagy modulation in cancer: Current knowledge on action and therapy. Oxid. Med. Cell Longev., 2018, 2018, 8023821.
[http://dx.doi.org/10.1155/2018/8023821]
[58]
Bhagya, N.; Chandrashekar, K.R. Autophagy and cancer: Can tetrandrine be a potent anticancer drug in the near future? Biomed. Pharmacother., 2022, 148, 112727.
[http://dx.doi.org/10.1016/j.biopha.2022.112727] [PMID: 35219119]
[59]
Wang, K.; Liu, R.; Li, J.; Mao, J.; Lei, Y.; Wu, J.; Zeng, J.; Zhang, T.; Wu, H.; Chen, L.; Huang, C.; Wei, Y. Quercetin induces protective autophagy in gastric cancer cells: Involvement of Akt-mTOR- and hypoxia-induced factor 1α-mediated signaling. Autophagy, 2011, 7(9), 966-978.
[http://dx.doi.org/10.4161/auto.7.9.15863] [PMID: 21610320]
[60]
Chang, J.L.; Chow, J.M.; Chang, J.H.; Wen, Y.C.; Lin, Y.W.; Yang, S.F.; Lee, W.J.; Chien, M.H. Quercetin simultaneously induces G0 /G1 -phase arrest and caspase-mediated crosstalk between apoptosis and autophagy in human leukemia HL-60 cells. Environ. Toxicol., 2017, 32(7), 1857-1868.
[http://dx.doi.org/10.1002/tox.22408] [PMID: 28251795]
[61]
Luo, C.; Liu, Y.; Wang, P.; Song, C.; Wang, K.; Dai, L.; Zhang, J.; Ye, H. The effect of quercetin nanoparticle on cervical cancer progression by inducing apoptosis, autophagy and anti-proliferation via JAK2 suppression. Biomed. Pharmacother., 2016, 82, 595-605.
[http://dx.doi.org/10.1016/j.biopha.2016.05.029] [PMID: 27470402]
[62]
Wang, Y.; Zhang, W.; Lv, Q.; Zhang, J.; Zhu, D. The critical role of quercetin in autophagy and apoptosis in HeLa cells. Tumour Biol., 2016, 37(1), 925-929.
[http://dx.doi.org/10.1007/s13277-015-3890-4] [PMID: 26260273]
[63]
Jia, L.; Huang, S.; Yin, X.; Zan, Y.; Guo, Y.; Han, L. Quercetin suppresses the mobility of breast cancer by suppressing glycolysis through Akt-mTOR pathway mediated autophagy induction. Life Sci., 2018, 208, 123-130.
[http://dx.doi.org/10.1016/j.lfs.2018.07.027] [PMID: 30025823]
[64]
Lee, P.I.; Li, J.X. Evolution of Oral Controlled Release Dosage Forms. In: Oral Controlled Release Formulation Design and Drug Delivery: Theory to Practice Wiley: Hoboken, New Jersey; , 2010; pp. 21-31.
[http://dx.doi.org/10.1002/9780470640487.ch2]
[65]
Yun, Y.H.; Lee, B.K.; Park, K. Controlled Drug Delivery: Historical perspective for the next generation. J. Control. Release, 2015, 219, 2-7.
[http://dx.doi.org/10.1016/j.jconrel.2015.10.005] [PMID: 26456749]
[66]
Ye, M.; Kim, S.; Park, K. Issues in long-term protein delivery using biodegradable microparticles. J. Control. Release, 2010, 146(2), 241-260.
[http://dx.doi.org/10.1016/j.jconrel.2010.05.011] [PMID: 20493221]
[67]
Lee, B.K.; Yun, Y.H.; Park, K. Smart nanoparticles for drug delivery: Boundaries and opportunities. Chem. Eng. Sci., 2015, 125, 158-164.
[http://dx.doi.org/10.1016/j.ces.2014.06.042] [PMID: 25684780]
[68]
Park, K. Controlled drug delivery systems: Past forward and future back. J. Control. Release, 2014, 190, 3-8.
[http://dx.doi.org/10.1016/j.jconrel.2014.03.054] [PMID: 24794901]
[69]
Dadwal, A.; Baldi, A.; Kumar Narang, R. Nanoparticles as carriers for drug delivery in cancer. Artif. Cells Nanomed. Biotechnol., 2018, 46(S2), 295-305.
[http://dx.doi.org/10.1080/21691401.2018.1457039]
[70]
Bahrami, B.; Hojjat-Farsangi, M.; Mohammadi, H.; Anvari, E.; Ghalamfarsa, G.; Yousefi, M.; Jadidi-Niaragh, F. Nanoparticles and targeted drug delivery in cancer therapy. Immunol. Lett., 2017, 190, 64-83.
[http://dx.doi.org/10.1016/j.imlet.2017.07.015] [PMID: 28760499]
[71]
Sultana, A.; Zare, M.; Thomas, V.; Kumar, T.S.; Ramakrishna, S. Nano-based drug delivery systems: Conventional drug delivery routes, recent developments and future prospects. Med. Drug Discovery, 2022, 15, 100134.
[72]
Zhao, J.; Yang, J.; Xie, Y. Improvement strategies for the oral bioavailability of poorly water-soluble flavonoids: An overview. Int. J. Pharm., 2019, 570, 118642.
[http://dx.doi.org/10.1016/j.ijpharm.2019.118642] [PMID: 31446024]
[73]
Chen, X.; Yin, O.Q.P.; Zuo, Z.; Chow, M.S.S. Pharmacokinetics and modeling of quercetin and metabolites. Pharm. Res., 2005, 22(6), 892-901.
[http://dx.doi.org/10.1007/s11095-005-4584-1] [PMID: 15948033]
[74]
Chabane, M.N.; Ahmad, A.A.; Peluso, J.; Muller, C.D.; Ubeaud-Séquier, G. Quercetin and naringenin transport across human intestinal Caco-2 cells. J. Pharm. Pharmacol., 2010, 61(11), 1473-1483.
[http://dx.doi.org/10.1211/jpp.61.11.0006] [PMID: 19903372]
[75]
Burak, C.; Brüll, V.; Langguth, P.; Zimmermann, B.F.; Stoffel-Wagner, B.; Sausen, U.; Stehle, P.; Wolffram, S.; Egert, S. Higher plasma quercetin levels following oral administration of an onion skin extract compared with pure quercetin dihydrate in humans. Eur. J. Nutr., 2017, 56(1), 343-353.
[http://dx.doi.org/10.1007/s00394-015-1084-x] [PMID: 26482244]
[76]
Guo, Y.; Bruno, R.S. Endogenous and exogenous mediators of quercetin bioavailability. J. Nutr. Biochem., 2015, 26(3), 201-210.
[http://dx.doi.org/10.1016/j.jnutbio.2014.10.008] [PMID: 25468612]
[77]
Sharma, G.; Park, J.; Sharma, A.R.; Jung, J.S.; Kim, H.; Chakraborty, C.; Song, D.K.; Lee, S.S.; Nam, J.S. Methoxy poly(ethylene glycol)-poly(lactide) nanoparticles encapsulating quercetin act as an effective anticancer agent by inducing apoptosis in breast cancer. Pharm. Res., 2015, 32(2), 723-735.
[http://dx.doi.org/10.1007/s11095-014-1504-2] [PMID: 25186442]
[78]
Chen, L-C.; Chen, Y-C.; Su, C-Y.; Hong, C-S.; Ho, H-O.; Sheu, M-T. Development and characterization of self-assembling lecithin-based mixed polymeric micelles containing quercetin in cancer treatment and an in vivo pharmacokinetic study. Int. J. Nanomedicine, 2016, 11, 1557-1566.
[PMID: 27143878]
[79]
Mero, A.; Campisi, M. Hyaluronic acid bioconjugates for the delivery of bioactive molecules. Polymers (Basel), 2014, 6(2), 346-369.
[http://dx.doi.org/10.3390/polym6020346]
[80]
De Leo, V.; Maurelli, A.M.; Giotta, L.; Catucci, L. Liposomes containing nanoparticles: preparation and applications. Colloids Surf. B Biointerfaces, 2022, 218, 112737.
[http://dx.doi.org/10.1016/j.colsurfb.2022.112737] [PMID: 35933888]
[81]
Dymek, M.; Sikora, E. Liposomes as biocompatible and smart delivery systems – the current state. Adv. Colloid Interface Sci., 2022, 309, 102757.
[http://dx.doi.org/10.1016/j.cis.2022.102757] [PMID: 36152374]
[82]
Aguilar-Pérez, K.M.; Avilés-Castrillo, J.I.; Medina, D.I.; Parra-Saldivar, R.; Iqbal, H.M.N. Insight into nanoliposomes as smart nanocarriers for greening the twenty-first century biomedical settings. Front. Bioeng. Biotechnol., 2020, 8, 579536.
[http://dx.doi.org/10.3389/fbioe.2020.579536] [PMID: 33384988]
[83]
Hynynen, K. Hyperthermia-induced drug delivery in humans. Nat. Biomed. Eng., 2018, 2(9), 637-639.
[http://dx.doi.org/10.1038/s41551-018-0297-8] [PMID: 31015680]
[84]
Deng, W.; Chen, W.; Clement, S.; Guller, A.; Zhao, Z.; Engel, A.; Goldys, E.M. Controlled gene and drug release from a liposomal delivery platform triggered by X-ray radiation. Nat. Commun., 2018, 9(1), 2713.
[http://dx.doi.org/10.1038/s41467-018-05118-3] [PMID: 30006596]
[85]
Hao, J.; Guo, B.; Yu, S.; Zhang, W.; Zhang, D.; Wang, J.; Wang, Y. Encapsulation of the flavonoid quercetin with chitosan-coated nano-liposomes. Lebensm. Wiss. Technol., 2017, 85, 37-44.
[http://dx.doi.org/10.1016/j.lwt.2017.06.048]
[86]
Li, J.; Shi, M.; Ma, B.; Niu, R.; Zhang, H.; Kun, L. Antitumor activity and safety evaluation of nanaparticle-based delivery of quercetin through intravenous administration in mice. Mater. Sci. Eng. C, 2017, 77, 803-810.
[http://dx.doi.org/10.1016/j.msec.2017.03.191] [PMID: 28532095]
[87]
Jiang, M.; Zhang, E.; Liang, Z.; Zhao, Y.; Zhang, S.; Xu, H.; Wang, H.; Shu, X.; Kang, X.; Sun, L.; Zhen, Y. Liposome-based co-delivery of 7-O-geranyl-quercetin and IGF-1R siRNA for the synergistic treatment of non-small cell lung cancer. J. Drug Deliv. Sci. Technol., 2019, 54, 101316.
[http://dx.doi.org/10.1016/j.jddst.2019.101316]
[88]
Yu, J.; Chen, H.; Jiang, L.; Wang, J.; Dai, J.; Wang, J. Codelivery of adriamycin and P-gp inhibitor quercetin using PEGylated liposomes to overcome cancer drug resistance. J. Pharm. Sci., 2019, 108(5), 1788-1799.
[http://dx.doi.org/10.1016/j.xphs.2018.12.016] [PMID: 30610857]
[89]
Patel, G.; Thakur, N.S.; Kushwah, V.; Patil, M.D.; Nile, S.H.; Jain, S.; Banerjee, U.C.; Kai, G. Liposomal delivery of mycophenolic acid with quercetin for improved breast cancer therapy in SD rats. Front. Bioeng. Biotechnol., 2020, 8, 631.
[http://dx.doi.org/10.3389/fbioe.2020.00631] [PMID: 32612988]
[90]
Cai, H.; Tan, P.; Chen, X.; Kopytynski, M.; Pan, D.; Zheng, X.; Gu, L.; Gong, Q.; Tian, X.; Gu, Z.; Zhang, H.; Chen, R.; Luo, K. Stimuli sensitive linear–dendritic block copolymer–drug prodrug as a nanoplatform for tumor combination therapy. Adv. Mater., 2022, 34(8), 2108049.
[http://dx.doi.org/10.1002/adma.202108049] [PMID: 34875724]
[91]
Li, Z.; Cai, H.; Li, Z.; Ren, L.; Ma, X.; Zhu, H.; Gong, Q.; Zhang, H.; Gu, Z.; Luo, K. A tumor cell membrane-coated self-amplified nanosystem as a nanovaccine to boost the therapeutic effect of anti-PD-L1 antibody. Bioact. Mater., 2023, 21, 299-312.
[http://dx.doi.org/10.1016/j.bioactmat.2022.08.028] [PMID: 36157245]
[92]
Xiao, X.; Cai, H.; Huang, Q.; Wang, B.; Wang, X.; Luo, Q.; Li, Y.; Zhang, H.; Gong, Q.; Ma, X.; Gu, Z.; Luo, K. Polymeric dual-modal imaging nanoprobe with two-photon aggregation-induced emission for fluorescence imaging and gadolinium-chelation for magnetic resonance imaging. Bioact. Mater., 2023, 19, 538-549.
[http://dx.doi.org/10.1016/j.bioactmat.2022.04.026] [PMID: 35600977]
[93]
Hemati, M.; Haghiralsadat, F.; Yazdian, F.; Jafari, F.; Moradi, A.; Malekpour-Dehkordi, Z. Development and characterization of a novel cationic PEGylated niosome-encapsulated forms of doxorubicin, quercetin and siRNA for the treatment of cancer by using combination therapy. Artif. Cells Nanomed. Biotechnol., 2019, 47(1), 1295-1311.
[http://dx.doi.org/10.1080/21691401.2018.1489271] [PMID: 30033768]
[94]
Aditya, N.P.; Ko, S. Solid lipid nanoparticles (SLNs): Delivery vehicles for food bioactives. RSC Advances, 2015, 5(39), 30902-30911.
[http://dx.doi.org/10.1039/C4RA17127F]
[95]
Ganesan, P.; Narayanasamy, D. Lipid nanoparticles: Different preparation techniques, characterization, hurdles, and strategies for the production of solid lipid nanoparticles and nanostructured lipid carriers for oral drug delivery. Sustain. Chem. Pharm., 2017, 6, 37-56.
[http://dx.doi.org/10.1016/j.scp.2017.07.002]
[96]
Nasirizadeh, S.; Malaekeh-Nikouei, B. Solid lipid nanoparticles and nanostructured lipid carriers in oral cancer drug delivery. J. Drug Deliv. Sci. Technol., 2020, 55, 101458.
[http://dx.doi.org/10.1016/j.jddst.2019.101458]
[97]
da Silva Santos, V.; Badan Ribeiro, A.P.; Andrade Santana, M.H. Solid lipid nanoparticles as carriers for lipophilic compounds for applications in foods. Food Res. Int., 2019, 122, 610-626.
[http://dx.doi.org/10.1016/j.foodres.2019.01.032] [PMID: 31229120]
[98]
Duan, Y.; Dhar, A.; Patel, C.; Khimani, M.; Neogi, S.; Sharma, P.; Siva Kumar, N.; Vekariya, R.L. A brief review on solid lipid nanoparticles: Part and parcel of contemporary drug delivery systems. RSC Advances, 2020, 10(45), 26777-26791.
[http://dx.doi.org/10.1039/D0RA03491F] [PMID: 35515778]
[99]
Hu, K.; Miao, L.; Goodwin, T.J.; Li, J.; Liu, Q.; Huang, L. Quercetin remodels the tumor microenvironment to improve the permeation, retention, and antitumor effects of nanoparticles. ACS Nano, 2017, 11(5), 4916-4925.
[http://dx.doi.org/10.1021/acsnano.7b01522] [PMID: 28414916]
[100]
Hu, X.; Ning, P.; Zhang, R.; Yang, Y.; Li, L.; Xiao, X. Anticancer effect of folic acid modified tumor-targeting quercetin lipid nanoparticle. Int. J. Clin. Exp. Med., 2016, 9(9), 17195-17202.
[101]
Weiss, J.; Decker, E.A.; McClements, D.J.; Kristbergsson, K.; Helgason, T.; Awad, T. Solid lipid nanoparticles as delivery systems for bioactive food components. Food Biophys., 2008, 3(2), 146-154.
[http://dx.doi.org/10.1007/s11483-008-9065-8]
[102]
Müller, R.H.; Mäder, K.; Gohla, S. Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. Eur. J. Pharm. Biopharm., 2000, 50(1), 161-177.
[http://dx.doi.org/10.1016/S0939-6411(00)00087-4] [PMID: 10840199]
[103]
Müller, R.H.; Radtke, M.; Wissing, S.A. Nanostructured lipid matrices for improved microencapsulation of drugs. Int. J. Pharm., 2002, 242(1-2), 121-128.
[http://dx.doi.org/10.1016/S0378-5173(02)00180-1] [PMID: 12176234]
[104]
Huang, Z.; Hua, S.; Yang, Y.; Fang, J. Development and evaluation of lipid nanoparticles for camptothecin delivery: A comparison of solid lipid nanoparticles, nanostructured lipid carriers, and lipid emulsion. Acta Pharmacol. Sin., 2008, 29(9), 1094-1102.
[http://dx.doi.org/10.1111/j.1745-7254.2008.00829.x] [PMID: 18718178]
[105]
Zhu, B.; Yu, L.; Yue, Q. Co-delivery of vincristine and quercetin by nanocarriers for lymphoma combination chemotherapy. Biomed. Pharmacother., 2017, 91, 287-294.
[http://dx.doi.org/10.1016/j.biopha.2017.02.112] [PMID: 28463792]
[106]
Kumar, R.; Choudhary, D.K.; Debnath, M. Development of BSA conjugated on modified surface of quercetin- loaded lipid nanocarriers for breast cancer treatment. Mater. Res. Express, 2020, 7(1), 015411.
[http://dx.doi.org/10.1088/2053-1591/ab6774]
[107]
Ghosh, S.; Mishra, P.; Dabke, A.; Pathak, A.; Bhowmick, S.; Misra, A. Targeting Approaches Using Polymeric Nanocarriers. In: Applications of Polymers in Drug Delivery; Elsevier: Amsterdam, 2021; pp. 393-421.
[http://dx.doi.org/10.1016/B978-0-12-819659-5.00014-8]
[108]
Prabhu, R.H.; Patravale, V.B.; Joshi, M.D. Polymeric nanoparticles for targeted treatment in oncology: Current insights. Int. J. Nanomedicine, 2015, 10, 1001-1018.
[PMID: 25678788]
[109]
Ekladious, I.; Colson, Y.L.; Grinstaff, M.W. Polymer–drug conjugate therapeutics: Advances, insights and prospects. Nat. Rev. Drug Discov., 2019, 18(4), 273-294.
[http://dx.doi.org/10.1038/s41573-018-0005-0] [PMID: 30542076]
[110]
Kumari, P.; Ghosh, B.; Biswas, S. Nanocarriers for cancer- targeted drug delivery. J. Drug Target., 2016, 24(3), 179-191.
[http://dx.doi.org/10.3109/1061186X.2015.1051049] [PMID: 26061298]
[111]
Alibolandi, M.; Ramezani, M.; Abnous, K.; Sadeghi, F.; Hadizadeh, F. Comparative evaluation of polymersome versus micelle structures as vehicles for the controlled release of drugs. J. Nanopart. Res., 2015, 17(2), 76.
[http://dx.doi.org/10.1007/s11051-015-2878-8]
[112]
Yokoyama, M. Polymeric micelles as drug carriers: Their lights and shadows. J. Drug Target., 2014, 22(7), 576-583.
[http://dx.doi.org/10.3109/1061186X.2014.934688] [PMID: 25012065]
[113]
Chaudhuri, A.; Ramesh, K.; Kumar, D.N.; Dehari, D.; Singh, S.; Kumar, D.; Agrawal, A.K. Polymeric micelles: A novel drug delivery system for the treatment of breast cancer. J. Drug Deliv. Sci. Technol., 2022, 77, 103886.
[http://dx.doi.org/10.1016/j.jddst.2022.103886]
[114]
Gao, X.; Wang, B.; Wei, X.; Men, K.; Zheng, F.; Zhou, Y.; Zheng, Y.; Gou, M.; Huang, M.; Guo, G.; Huang, N.; Qian, Z.; Wei, Y. Anticancer effect and mechanism of polymer micelle-encapsulated quercetin on ovarian cancer. Nanoscale, 2012, 4(22), 7021-7030.
[http://dx.doi.org/10.1039/c2nr32181e] [PMID: 23044718]
[115]
Fatease, A.A.; Shah, V.; Nguyen, D.X.; Cote, B.; LeBlanc, N.; Rao, D.A.; Alani, A.W.G. Chemosensitization and mitigation of Adriamycin-induced cardiotoxicity using combinational polymeric micelles for co-delivery of quercetin/resveratrol and resveratrol/curcumin in ovarian cancer. Nanomedicine, 2019, 19, 39-48.
[http://dx.doi.org/10.1016/j.nano.2019.03.011] [PMID: 31022465]
[116]
Qureshi, W.A.; Zhao, R.; Wang, H.; Ji, T.; Ding, Y.; Ihsan, A.; Mujeeb, A.; Nie, G.; Zhao, Y. Co-delivery of doxorubicin and quercetin via mPEG–PLGA copolymer assembly for synergistic anti-tumor efficacy and reducing cardio- toxicity. Sci. Bull. (Beijing), 2016, 61(21), 1689-1698.
[http://dx.doi.org/10.1007/s11434-016-1182-z]
[117]
Ramasamy, T.; Ruttala, H.B.; Chitrapriya, N.; Poudal, B.K.; Choi, J.Y.; Kim, S.T.; Youn, Y.S.; Ku, S.K.; Choi, H.G.; Yong, C.S.; Kim, J.O. Engineering of cell microenvironment-responsive polypeptide nanovehicle co-encapsulating a synergistic combination of small molecules for effective chemotherapy in solid tumors. Acta Biomater., 2017, 48, 131-143.
[http://dx.doi.org/10.1016/j.actbio.2016.10.034] [PMID: 27794477]
[118]
Zhang, X.; Huang, Y.; Song, H.; Canup, B.S.B.; Gou, S.; She, Z.; Dai, F.; Ke, B.; Xiao, B. Inhibition of growth and lung metastasis of breast cancer by tumor-homing triple-bioresponsive nanotherapeutics. J. Control. Release, 2020, 328, 454-469.
[http://dx.doi.org/10.1016/j.jconrel.2020.08.066] [PMID: 32890553]
[119]
Wang, Y.; Yu, H.; Wang, S.; Gai, C.; Cui, X.; Xu, Z.; Li, W.; Zhang, W. Targeted delivery of quercetin by nanoparticles based on chitosan sensitizing paclitaxel-resistant lung cancer cells to paclitaxel. Mater. Sci. Eng. C, 2021, 119, 111442.
[http://dx.doi.org/10.1016/j.msec.2020.111442] [PMID: 33321583]
[120]
Xiong, Q.; Wang, Y.; Wan, J.; Yuan, P.; Chen, H.; Zhang, L. Facile preparation of hyaluronic acid-based quercetin nanoformulation for targeted tumor therapy. Int. J. Biol. Macromol., 2020, 147, 937-945.
[http://dx.doi.org/10.1016/j.ijbiomac.2019.10.060] [PMID: 31730969]
[121]
Gu, L.Q.; Cui, P.F.; Xing, L.; He, Y.J.; Chang, X.; Zhou, T.J.; Liu, Y.; Li, L.; Jiang, H.L. An energy-blocking nanoparticle decorated with anti-VEGF antibody to reverse chemotherapeutic drug resistance. RSC Advances, 2019, 9(21), 12110-12123.
[http://dx.doi.org/10.1039/C9RA01356C] [PMID: 35548379]
[122]
Ersoz, M.; Erdemir, A.; Derman, S.; Arasoglu, T.; Mansuroglu, B. Quercetin-loaded nanoparticles enhance cytotoxicity and antioxidant activity on C6 glioma cells. Pharm. Dev. Technol., 2020, 25(6), 757-766.
[http://dx.doi.org/10.1080/10837450.2020.1740933] [PMID: 32192406]
[123]
Tian, F.; Dahmani, F.Z.; Qiao, J.; Ni, J.; Xiong, H.; Liu, T.; Zhou, J.; Yao, J. A targeted nanoplatform co-delivering chemotherapeutic and antiangiogenic drugs as a tool to reverse multidrug resistance in breast cancer. Acta Biomater., 2018, 75, 398-412.
[http://dx.doi.org/10.1016/j.actbio.2018.05.050] [PMID: 29874597]
[124]
Mu, Y.; Fu, Y.; Li, J.; Yu, X.; Li, Y.; Wang, Y.; Wu, X.; Zhang, K.; Kong, M.; Feng, C.; Chen, X. Multifunctional quercetin conjugated chitosan nano-micelles with P-gp inhibition and permeation enhancement of anticancer drug. Carbohydr. Polym., 2019, 203, 10-18.
[http://dx.doi.org/10.1016/j.carbpol.2018.09.020] [PMID: 30318192]
[125]
Mu, Y.; Wu, G.; Su, C.; Dong, Y.; Zhang, K.; Li, J.; Sun, X.; Li, Y.; Chen, X.; Feng, C. pH-sensitive amphiphilic chitosan-quercetin conjugate for intracellular delivery of doxorubicin enhancement. Carbohydr. Polym., 2019, 223, 115072.
[http://dx.doi.org/10.1016/j.carbpol.2019.115072] [PMID: 31427010]
[126]
Zhang, J.; Shen, L.; Li, X.; Song, W.; Liu, Y.; Huang, L. Nanoformulated codelivery of quercetin and alantolactone promotes an antitumor response through synergistic immunogenic cell death for microsatellite-stable colorectal cancer. ACS Nano, 2019, 13(11), 12511-12524.
[http://dx.doi.org/10.1021/acsnano.9b02875] [PMID: 31664821]
[127]
Rezvani, M.; Mohammadnejad, J.; Narmani, A.; Bidaki, K. Synthesis and in vitro study of modified chitosan-polycaprolactam nanocomplex as delivery system. Int. J. Biol. Macromol., 2018, 113, 1287-1293.
[http://dx.doi.org/10.1016/j.ijbiomac.2018.02.141] [PMID: 29481956]
[128]
Zamani, M.; Aghajanzadeh, M.; Rostamizadeh, K.; Kheiri Manjili, H.; Fridoni, M.; Danafar, H. In vivo study of poly (ethylene glycol)-poly (caprolactone)-modified folic acid nanocarriers as a pH responsive system for tumor-targeted co-delivery of tamoxifen and quercetin. J. Drug Deliv. Sci. Technol., 2019, 54, 101283.
[http://dx.doi.org/10.1016/j.jddst.2019.101283]
[129]
Zhou, L.; Shan, Y.; Hu, H.; Yu, B.; Cong, H. Synthesis and biomedical applications of dendrimers. Curr. Org. Chem., 2018, 22(6), 600-612.
[http://dx.doi.org/10.2174/1385272822666180129142809]
[130]
Yousefi, M.; Narmani, A.; Jafari, S.M. Dendrimers as efficient nanocarriers for the protection and delivery of bioactive phytochemicals. Adv. Colloid Interface Sci., 2020, 278, 102125.
[http://dx.doi.org/10.1016/j.cis.2020.102125] [PMID: 32109595]
[131]
Patel, P.; Patel, V.; Patel, P.M. Synthetic strategy of dendrimers: A review. J. Indian Chem. Soc., 2022, 99(7), 100514.
[http://dx.doi.org/10.1016/j.jics.2022.100514]
[132]
Choi, J.; Moquin, A.; Bomal, E.; Na, L.; Maysinger, D.; Kakkar, A. Telodendrimers for physical encapsulation and covalent linking of individual or combined therapeutics. Mol. Pharm., 2017, 14(8), 2607-2615.
[http://dx.doi.org/10.1021/acs.molpharmaceut.7b00019] [PMID: 28520445]
[133]
Eivazzadeh-Keihan, R.; Maleki, A.; de la Guardia, M.; Bani, M.S.; Chenab, K.K.; Pashazadeh-Panahi, P.; Baradaran, B.; Mokhtarzadeh, A.; Hamblin, M.R. Carbon based nanomaterials for tissue engineering of bone: Building new bone on small black scaffolds: A review. J. Adv. Res., 2019, 18, 185-201.
[http://dx.doi.org/10.1016/j.jare.2019.03.011] [PMID: 31032119]
[134]
Bianco, A. Carbon nanotubes for the delivery of therapeutic molecules. Expert Opin. Drug Deliv., 2004, 1(1), 57-65.
[http://dx.doi.org/10.1517/17425247.1.1.57] [PMID: 16296720]
[135]
Deepa, C.; Rajeshkumar, L.; Ramesh, M. Preparation, synthesis, properties and characterization of graphene-based 2D nano-materials for biosensors and bioelectronics. J. Mater. Res. Technol., 2022, 19, 2657-2694.
[http://dx.doi.org/10.1016/j.jmrt.2022.06.023]
[136]
Kostarelos, K.; Lacerda, L.; Pastorin, G.; Wu, W.; Wieckowski, S.; Luangsivilay, J.; Godefroy, S.; Pantarotto, D.; Briand, J.P.; Muller, S.; Prato, M.; Bianco, A. Cellular uptake of functionalized carbon nanotubes is independent of functional group and cell type. Nat. Nanotechnol., 2007, 2(2), 108-113.
[http://dx.doi.org/10.1038/nnano.2006.209] [PMID: 18654229]
[137]
Kumar, M.; Sharma, G.; Misra, C.; Kumar, R.; Singh, B.; Katare, O.P.; Raza, K. N-desmethyl tamoxifen and quercetin-loaded multiwalled CNTs: A synergistic approach to overcome MDR in cancer cells. Mater. Sci. Eng. C, 2018, 89, 274-282.
[http://dx.doi.org/10.1016/j.msec.2018.03.033] [PMID: 29752099]
[138]
Badea, N.; Craciun, M.M.; Dragomir, A.S.; Balas, M.; Dinischiotu, A.; Nistor, C.; Gavan, C.; Ionita, D. Systems based on carbon nanotubes with potential in cancer therapy. Mater. Chem. Phys., 2020, 241, 122435.
[http://dx.doi.org/10.1016/j.matchemphys.2019.122435]
[139]
Gismondi, A.; Reina, G.; Orlanducci, S.; Mizzoni, F.; Gay, S.; Terranova, M.L.; Canini, A. Nanodiamonds coupled with plant bioactive metabolites: A nanotech approach for cancer therapy. Biomaterials, 2015, 38, 22-35.
[http://dx.doi.org/10.1016/j.biomaterials.2014.10.057] [PMID: 25457980]
[140]
Tiwari, H.; Karki, N.; Pal, M.; Basak, S.; Verma, R.K.; Bal, R.; Kandpal, N.D.; Bisht, G.; Sahoo, N.G. Functionalized graphene oxide as a nanocarrier for dual drug delivery applications: The synergistic effect of quercetin and gefitinib against ovarian cancer cells. Colloids Surf. B Biointerfaces, 2019, 178, 452-459.
[http://dx.doi.org/10.1016/j.colsurfb.2019.03.037] [PMID: 30921680]
[141]
Abdallah, B.; Elhissi, A.; Ahmed, W.; Najlah, M. Chapter 16 - Carbon nanotubes drug delivery system for cancer treatment. Adv. Med. Surgic. Eng., 2020, 313-332.
[142]
Huang, Y.; Li, P.; Zhao, R.; Zhao, L.; Liu, J.; Peng, S.; Fu, X.; Wang, X.; Luo, R.; Wang, R.; Zhang, Z. Silica nanoparticles: Biomedical applications and toxicity. Biomed. Pharmacother., 2022, 151, 113053.
[http://dx.doi.org/10.1016/j.biopha.2022.113053] [PMID: 35594717]
[143]
Siddiqui, B.; Rehman, A.; Haq, I.; Al-Dossary, A.A.; Elaissari, A.; Ahmed, N. Exploiting recent trends for the synthesis and surface functionalization of mesoporous silica nanoparticles towards biomedical applications. Int. J. Pharm. X, 2022, 4, 100116.
[http://dx.doi.org/10.1016/j.ijpx.2022.100116] [PMID: 35509288]
[144]
Murugan, C.; Rayappan, K.; Thangam, R.; Bhanumathi, R.; Shanthi, K.; Vivek, R.; Thirumurugan, R.; Bhattacharyya, A.; Sivasubramanian, S.; Gunasekaran, P.; Kannan, S. Combinatorial nanocarrier based drug delivery approach for amalgamation of anti-tumor agents in breast cancer cells: an improved nanomedicine strategy. Sci. Rep., 2016, 6(1), 34053.
[http://dx.doi.org/10.1038/srep34053] [PMID: 28442746]
[145]
Sarkar, A.; Ghosh, S.; Chowdhury, S.; Pandey, B.; Sil, P.C. Targeted delivery of quercetin loaded mesoporous silica nanoparticles to the breast cancer cells. Biochim. Biophys. Acta, Gen. Subj., 2016, 1860(10), 2065-2075.
[http://dx.doi.org/10.1016/j.bbagen.2016.07.001] [PMID: 27392941]
[146]
Mishra, S.; Manna, K.; Kayal, U.; Saha, M.; Chatterjee, S.; Chandra, D.; Hara, M.; Datta, S.; Bhaumik, A.; Das Saha, K. Folic acid-conjugated magnetic mesoporous silica nanoparticles loaded with quercetin: A theranostic approach for cancer management. RSC Advances, 2020, 10(39), 23148-23164.
[http://dx.doi.org/10.1039/D0RA00664E] [PMID: 35520307]
[147]
Evans, E.R.; Bugga, P.; Asthana, V.; Drezek, R. Metallic nanoparticles for cancer immunotherapy. Mater. Today, 2018, 21(6), 673-685.
[http://dx.doi.org/10.1016/j.mattod.2017.11.022] [PMID: 30197553]
[148]
El-Sayed, M.A. Some interesting properties of metals confined in time and nanometer space of different shapes. Acc. Chem. Res., 2001, 34(4), 257-264.
[http://dx.doi.org/10.1021/ar960016n] [PMID: 11308299]
[149]
Khursheed, R.; Dua, K.; Vishwas, S.; Gulati, M.; Jha, N.K.; Aldhafeeri, G.M.; Alanazi, F.G.; Goh, B.H.; Gupta, G.; Paudel, K.R.; Hansbro, P.M.; Chellappan, D.K.; Singh, S.K. Biomedical applications of metallic nanoparticles in cancer: Current status and future perspectives. Biomed. Pharmacother., 2022, 150, 112951.
[http://dx.doi.org/10.1016/j.biopha.2022.112951] [PMID: 35447546]
[150]
Bishayee, K.; Khuda-Bukhsh, A.R.; Huh, S.O. PLGA-loaded gold-nanoparticles precipitated with quercetin downregulate HDAC-Akt activities controlling proliferation and activate p53-ROS crosstalk to induce apoptosis in hepatocarcinoma cells. Mol. Cells, 2015, 38(6), 518-527.
[http://dx.doi.org/10.14348/molcells.2015.2339] [PMID: 25947292]
[151]
Balakrishnan, S.; Mukherjee, S.; Das, S.; Bhat, F.A.; Raja Singh, P.; Patra, C.R.; Arunakaran, J. Gold nanoparticles- conjugated quercetin induces apoptosis via inhibition of EGFR/PI3K/Akt-mediated pathway in breast cancer cell lines (MCF-7 and MDA-MB-231). Cell Biochem. Funct., 2017, 35(4), 217-231.
[http://dx.doi.org/10.1002/cbf.3266] [PMID: 28498520]
[152]
Balakrishnan, S.; Bhat, F.A.; Raja Singh, P.; Mukherjee, S.; Elumalai, P.; Das, S.; Patra, C.R.; Arunakaran, J. Gold nanoparticle-conjugated quercetin inhibits epithelial-mesenchymal transition, angiogenesis and invasiveness via EGFR/VEGFR-2-mediated pathway in breast cancer. Cell Prolif., 2016, 49(6), 678-697.
[http://dx.doi.org/10.1111/cpr.12296] [PMID: 27641938]
[153]
Daglioglu, C. Enhancing tumor cell response to multidrug resistance with pH-sensitive quercetin and doxorubicin conjugated multifunctional nanoparticles. Colloids Surf. B Biointerfaces, 2017, 156, 175-185.
[http://dx.doi.org/10.1016/j.colsurfb.2017.05.012] [PMID: 28528134]
[154]
Mashhadi Malekzadeh, A.; Ramazani, A.; Tabatabaei Rezaei, S.J.; Niknejad, H. Design and construction of multifunctional hyperbranched polymers coated magnetite nanoparticles for both targeting magnetic resonance imaging and cancer therapy. J. Colloid Interface Sci., 2017, 490, 64-73.
[http://dx.doi.org/10.1016/j.jcis.2016.11.014] [PMID: 27870961]
[155]
Akal, Z.Ü.; Alpsoy, L.; Baykal, A. Biomedical applications of SPION@APTES@PEG-folic acid@carboxylated quercetin nanodrug on various cancer cells. Appl. Surf. Sci., 2016, 378, 572-581.
[http://dx.doi.org/10.1016/j.apsusc.2016.03.217]
[156]
Sathishkumar, P.; Li, Z.; Govindan, R.; Jayakumar, R.; Wang, C.; Long Gu, F. Zinc oxide-quercetin nanocomposite as a smart nano-drug delivery system: Molecular-level interaction studies. Appl. Surf. Sci., 2021, 536, 147741.
[http://dx.doi.org/10.1016/j.apsusc.2020.147741]
[157]
George, D.; Maheswari, P.U.; Begum, K.M.M.S. Chitosan-cellulose hydrogel conjugated with L-histidine and zinc oxide nanoparticles for sustained drug delivery: Kinetics and in-vitro biological studies. Carbohydr. Polym., 2020, 236, 116101.
[http://dx.doi.org/10.1016/j.carbpol.2020.116101] [PMID: 32172900]
[158]
Sadhukhan, P.; Kundu, M.; Chatterjee, S.; Ghosh, N.; Manna, P.; Das, J.; Sil, P.C. Targeted delivery of quercetin via pH-responsive zinc oxide nanoparticles for breast cancer therapy. Mater. Sci. Eng. C, 2019, 100, 129-140.
[http://dx.doi.org/10.1016/j.msec.2019.02.096] [PMID: 30948047]
[159]
Cheng, H.W.; Chiang, C.S.; Ho, H.Y.; Chou, S.H.; Lai, Y.H.; Shyu, W.C.; Chen, S.Y. Dextran-modified Quercetin-Cu(II)/hyaluronic acid nanomedicine with natural poly(ADP-ribose) polymerase inhibitor and dual targeting for programmed synthetic lethal therapy in triple-negative breast cancer. J. Control. Release, 2021, 329, 136-147.
[http://dx.doi.org/10.1016/j.jconrel.2020.11.061] [PMID: 33278482]
[160]
Ponraj, T.; Vivek, R.; Paulpandi, M.; Rejeeth, C.; Nipun Babu, V.; Vimala, K.; Anand, K.; Sivaselvam, S.; Vasanthakumar, A.; Ponpandian, N.; Kannan, S. Mitochondrial dysfunction-induced apoptosis in breast carcinoma cells through a pH-dependent intracellular quercetin NDDS of PVPylated-TiO 2 NPs. J. Mater. Chem. B Mater. Biol. Med., 2018, 6(21), 3555-3570.
[http://dx.doi.org/10.1039/C8TB00769A] [PMID: 32254451]
[161]
Klein, S.; Luchs, T.; Leng, A.; Distel, L.; Neuhuber, W.; Hirsch, A. Encapsulation of hydrophobic drugs in shell-by-shell coated nanoparticles for radio-and chemotherapy-An in vitro study. Bioengineering (Basel), 2020, 7(4), 126.
[http://dx.doi.org/10.3390/bioengineering7040126] [PMID: 33053776]
[162]
Zhong, Y.; Zou, Y.; Liu, L.; Li, R.; Xue, F.; Yi, T. pH-responsive Ag2S nanodots loaded with heat shock protein 70 inhibitor for photoacoustic imaging-guided photothermal cancer therapy. Acta Biomater., 2020, 115, 358-370.
[http://dx.doi.org/10.1016/j.actbio.2020.08.007] [PMID: 32798720]
[163]
Bose, P.; Priyam, A.; Kar, R.; Pattanayak, S.P. Quercetin loaded folate targeted plasmonic silver nanoparticles for light activated chemo-photothermal therapy of DMBA induced breast cancer in Sprague Dawley rats. RSC Advances, 2020, 10(53), 31961-31978.
[http://dx.doi.org/10.1039/D0RA05793B] [PMID: 35518142]
[164]
Ma, T.; Liu, Y.; Wu, Q.; Luo, L.; Cui, Y.; Wang, X.; Chen, X.; Tan, L.; Meng, X. Quercetin-modified metal–organic frameworks for dual sensitization of radiotherapy in tumor tissues by inhibiting the carbonic anhydrase IX. ACS Nano, 2019, 13(4), 4209-4219.
[http://dx.doi.org/10.1021/acsnano.8b09221] [PMID: 30933559]
[165]
Chen, Z.; Guo, W.; Wu, Q.; Tan, L.; Ma, T.; Fu, C.; Yu, J.; Ren, X.; Wang, J.; Liang, P.; Meng, X. Tumor reoxygenation for enhanced combination of radiation therapy and microwave thermal therapy using oxygen generation in situ by CuO nanosuperparticles under microwave irradiation. Theranostics, 2020, 10(10), 4659-4675.
[http://dx.doi.org/10.7150/thno.42818] [PMID: 32292521]
[166]
Rezaei-Sadabady, R.; Eidi, A.; Zarghami, N.; Barzegar, A. Intracellular ROS protection efficiency and free radical-scavenging activity of quercetin and quercetin-encapsulated liposomes. Artif. Cells Nanomed. Biotechnol., 2016, 44(1), 128-134.
[http://dx.doi.org/10.3109/21691401.2014.926456] [PMID: 24959911]
[167]
Zhang, J.; Luo, Y.; Zhao, X.; Li, X.; Li, K.; Chen, D.; Qiao, M.; Hu, H.; Zhao, X. Co-delivery of doxorubicin and the traditional Chinese medicine quercetin using biotin–PEG 2000 –DSPE modified liposomes for the treatment of multidrug resistant breast cancer. RSC Advances, 2016, 6(114), 113173-113184.
[http://dx.doi.org/10.1039/C6RA24173E]
[168]
Patel, G.; Thakur, N.S.; Kushwah, V.; Patil, M.D.; Nile, S.H.; Jain, S.; Kai, G.; Banerjee, U.C. Mycophenolate co-administration with quercetin via lipid-polymer hybrid nanoparticles for enhanced breast cancer management. Nanomedicine, 2020, 24, 102147.
[http://dx.doi.org/10.1016/j.nano.2019.102147] [PMID: 31884040]
[169]
Jain, A.S.; Shah, S.M.; Nagarsenker, M.S.; Nikam, Y.; Gude, R.P.; Steiniger, F.; Thamm, J.; Fahr, A. Lipid colloidal carriers for improvement of anticancer activity of orally delivered quercetin: formulation, characterization and establishing in vitro-in vivo advantage. J. Biomed. Nanotechnol., 2013, 9(7), 1230-1240.
[http://dx.doi.org/10.1166/jbn.2013.1636] [PMID: 23909137]
[170]
Jain, A.K.; Thanki, K.; Jain, S. Novel self-nanoemulsifying formulation of quercetin: Implications of pro-oxidant activity on the anticancer efficacy. Nanomedicine, 2014, 10(5), e959-e969.
[http://dx.doi.org/10.1016/j.nano.2013.12.010] [PMID: 24407148]
[171]
Samadi, A.; Pourmadadi, M.; Yazdian, F.; Rashedi, H.; Navaei-Nigjeh, M.; Eufrasio-da-silva, T. Ameliorating quercetin constraints in cancer therapy with pH-responsive agarose-polyvinylpyrrolidone -hydroxyapatite nanocomposite encapsulated in double nanoemulsion. Int. J. Biol. Macromol., 2021, 182, 11-25.
[http://dx.doi.org/10.1016/j.ijbiomac.2021.03.146] [PMID: 33775763]
[172]
Wang, G.; Wang, J.; Luo, J.; Wang, L.; Chen, X.; Zhang, L.; Jiang, S. PEG2000-DPSE-coated quercetin nanoparticles remarkably enhanced anticancer effects through induced programed cell death on C6 glioma cells. J. Biomed. Mater. Res. A, 2013, 101(11), n/a.
[http://dx.doi.org/10.1002/jbm.a.34607] [PMID: 23529952]
[173]
El-Gogary, R.I.; Rubio, N.; Wang, J.T.W.; Al-Jamal, W.T.; Bourgognon, M.; Kafa, H.; Naeem, M.; Klippstein, R.; Abbate, V.; Leroux, F.; Bals, S.; Van Tendeloo, G.; Kamel, A.O.; Awad, G.A.S.; Mortada, N.D.; Al-Jamal, K.T. Polyethylene glycol conjugated polymeric nanocapsules for targeted delivery of quercetin to folate-expressing cancer cells in vitro and in vivo. ACS Nano, 2014, 8(2), 1384-1401.
[http://dx.doi.org/10.1021/nn405155b] [PMID: 24397686]
[174]
Pang, X.; Lu, Z.; Du, H.; Yang, X.; Zhai, G. Hyaluronic acid-quercetin conjugate micelles: Synthesis, characterization, in vitro and in vivo evaluation. Colloids Surf. B Biointerfaces, 2014, 123, 778-786.
[http://dx.doi.org/10.1016/j.colsurfb.2014.10.025] [PMID: 25454664]
[175]
Zafar, S.; Negi, L.M.; Verma, A.K.; Kumar, V.; Tyagi, A.; Singh, P.; Iqbal, Z.; Talegaonkar, S. Sterically stabilized polymeric nanoparticles with a combinatorial approach for multi drug resistant cancer: In vitro and in vivo investigations. Int. J. Pharm., 2014, 477(1-2), 454-468.
[http://dx.doi.org/10.1016/j.ijpharm.2014.10.061] [PMID: 25445525]
[176]
David, K.I.; Jaidev, L.R.; Sethuraman, S.; Krishnan, U.M. Dual drug loaded chitosan nanoparticles-sugar-coated arsenal against pancreatic cancer. Colloids Surf. B Biointerfaces, 2015, 135, 689-698.
[http://dx.doi.org/10.1016/j.colsurfb.2015.08.038] [PMID: 26340358]
[177]
Suksiriworapong, J.; Phoca, K.; Ngamsom, S.; Sripha, K.; Moongkarndi, P.; Junyaprasert, V.B. Comparison of poly(ε-caprolactone) chain lengths of poly(ε-caprolactone)- co-d-α-tocopheryl-poly(ethylene glycol) 1000 succinate nanoparticles for enhancement of quercetin delivery to SKBR3 breast cancer cells. Eur. J. Pharm. Biopharm., 2016, 101, 15-24.
[http://dx.doi.org/10.1016/j.ejpb.2016.01.008] [PMID: 26802701]
[178]
Abd-Rabou, A.A.; Ahmed, H.H. CS-PEG decorated PLGA nano-prototype for delivery of bioactive compounds: A novel approach for induction of apoptosis in HepG2 cell line. Adv. Med. Sci., 2017, 62(2), 357-367.
[http://dx.doi.org/10.1016/j.advms.2017.01.003] [PMID: 28521254]
[179]
Baksi, R.; Singh, D.P.; Borse, S.P.; Rana, R.; Sharma, V.; Nivsarkar, M. In vitro and in vivo anticancer efficacy potential of Quercetin loaded polymeric nanoparticles. Biomed. Pharmacother., 2018, 106, 1513-1526.
[http://dx.doi.org/10.1016/j.biopha.2018.07.106] [PMID: 30119227]
[180]
Desale, J.P.; Swami, R.; Kushwah, V.; Katiyar, S.S.; Jain, S. Chemosensitizer and docetaxel-loaded albumin nanoparticle: Overcoming drug resistance and improving therapeutic efficacy. Nanomedicine, 2018, 13(21), 2759-2776.
[http://dx.doi.org/10.2217/nnm-2018-0206] [PMID: 30398388]
[181]
Halder, A.; Mukherjee, P.; Ghosh, S.; Mandal, S.; Chatterji, U.; Mukherjee, A. Smart PLGA nanoparticles loaded with Quercetin: Cellular uptake and in vitro anticancer study. Mater. Today Proc., 2018, 5(3), 9698-9705.
[http://dx.doi.org/10.1016/j.matpr.2017.10.156]
[182]
Islami, M.; Zarrabi, A.; Tada, S.; Kawamoto, M.; Isoshima, T.; Ito, Y. Controlled quercetin release from high-capacity-loading hyperbranched polyglycerol-functionalized graphene oxide. Int. J. Nanomedicine, 2018, 13, 6059-6071.
[http://dx.doi.org/10.2147/IJN.S178374] [PMID: 30323593]
[183]
Oliver, S.; Yee, E.; Kavallaris, M.; Vittorio, O.; Boyer, C. Water soluble antioxidant dextran–quercetin conjugate with potential anticancer properties. Macromol. Biosci., 2018, 18(4), 1700239.
[http://dx.doi.org/10.1002/mabi.201700239] [PMID: 29411934]
[184]
Sahiner, N.; Sagbas, S.; Sahiner, M.; Aktas, N. Degradable natural phenolic based particles with micro-and nano-size range. Recent Pat. Mater. Sci., 2018, 11(1), 33-40.
[http://dx.doi.org/10.2174/1874464811666180724124614]
[185]
Sunoqrot, S.; Al-Shalabi, E.; Messersmith, P.B. Facile synthesis and surface modification of bioinspired nanoparticles from quercetin for drug delivery. Biomater. Sci., 2018, 6(10), 2656-2666.
[http://dx.doi.org/10.1039/C8BM00587G] [PMID: 30140818]
[186]
Sunoqrot, S.; Abujamous, L. pH-sensitive polymeric nanoparticles of quercetin as a potential colon cancer-targeted nanomedicine. J. Drug Deliv. Sci. Technol., 2019, 52, 670-676.
[http://dx.doi.org/10.1016/j.jddst.2019.05.035]
[187]
Wang, B.; Zhang, W.; Zhou, X.; Liu, M.; Hou, X.; Cheng, Z.; Chen, D. Development of dual-targeted nano-dandelion based on an oligomeric hyaluronic acid polymer targeting tumor-associated macrophages for combination therapy of non-small cell lung cancer. Drug Deliv., 2019, 26(1), 1265-1279.
[http://dx.doi.org/10.1080/10717544.2019.1693707] [PMID: 31777307]
[188]
Mansourizadeh, F.; Alberti, D.; Bitonto, V.; Tripepi, M.; Sepehri, H.; Khoee, S.; Geninatti Crich, S. Efficient synergistic combination effect of Quercetin with Curcumin on breast cancer cell apoptosis through their loading into Apo ferritin cavity. Colloids Surf. B Biointerfaces, 2020, 191, 110982.
[http://dx.doi.org/10.1016/j.colsurfb.2020.110982] [PMID: 32220813]
[189]
Qiao, Y.; Cao, Y.; Yu, K.; Zong, L.; Pu, X. Preparation and antitumor evaluation of quercetin nanosuspensions with synergistic efficacy and regulating immunity. Int. J. Pharm., 2020, 589, 119830.
[http://dx.doi.org/10.1016/j.ijpharm.2020.119830] [PMID: 32877732]
[190]
Rofeal, M.G.; Elzoghby, A.O.; Helmy, M.W.; Khalil, R.; Khairy, H.; Omar, S. Dual therapeutic targeting of lung infection and carcinoma using lactoferrin-based green nanomedicine. ACS Biomater. Sci. Eng., 2020, 6(10), 5685-5699.
[http://dx.doi.org/10.1021/acsbiomaterials.0c01095] [PMID: 33320553]
[191]
Shen, Y.; TanTai, J. Co-delivery anticancer drug nanoparticles for synergistic therapy against lung cancer cells. Drug Des. Devel. Ther., 2020, 14, 4503-4510.
[http://dx.doi.org/10.2147/DDDT.S275123] [PMID: 33122893]
[192]
Shitole, A.A.; Sharma, N.; Giram, P.; Khandwekar, A.; Baruah, M.; Garnaik, B.; Koratkar, S. LHRH-conjugated, PEGylated, poly-lactide-co-glycolide nanocapsules for targeted delivery of combinational chemotherapeutic drugs Docetaxel and Quercetin for prostate cancer. Mater. Sci. Eng. C, 2020, 114, 111035.
[http://dx.doi.org/10.1016/j.msec.2020.111035] [PMID: 32994029]
[193]
Tian, H.; Zhang, J.; Zhang, H.; Jiang, Y.; Song, A.; Luan, Y. Low side-effect and heat-shock protein-inhibited chemo-phototherapy nanoplatform via co-assembling strategy of biotin-tailored IR780 and quercetin. Chem. Eng. J., 2020, 382, 123043.
[http://dx.doi.org/10.1016/j.cej.2019.123043]
[194]
Wang, B.; Guo, C.; Liu, Y.; Han, G.; Li, Y.; Zhang, Y.; Xu, H.; Chen, D. Novel nano-pomegranates based on astragalus polysaccharides for targeting ERα-positive breast cancer and multidrug resistance. Drug Deliv., 2020, 27(1), 607-621.
[http://dx.doi.org/10.1080/10717544.2020.1754529] [PMID: 32308054]
[195]
Wang, T.; Wu, C.; Li, T.; Fan, G.; Gong, H.; Liu, P.; Yang, Y.; Sun, L. Comparison of two nanocarriers for quercetin in morphology, loading behavior, release kinetics and cell inhibitory activity. Mater. Express, 2020, 10(10), 1589-1598.
[http://dx.doi.org/10.1166/mex.2020.1796]
[196]
Nematollahi, E.; Pourmadadi, M.; Yazdian, F.; Fatoorehchi, H.; Rashedi, H.; Nigjeh, M.N. Synthesis and characterization of chitosan/polyvinylpyrrolidone coated nanoporous γ-Alumina as a pH-sensitive carrier for controlled release of quercetin. Int. J. Biol. Macromol., 2021, 183, 600-613.
[http://dx.doi.org/10.1016/j.ijbiomac.2021.04.160] [PMID: 33932424]
[197]
Wang, J.; Cheng, H.; Wang, Z.; Yang, E.; Guo, F.; Wang, W.; Sun, D. Human small intestine cancer cell membrane-camouflaged quercetin-melanin for antibacterial and antitumor activity. J. Biomed. Mater. Res. B Appl. Biomater., 2021, 109(10), 1534-1551.
[http://dx.doi.org/10.1002/jbm.b.34813] [PMID: 33559310]
[198]
Rahmanian, N.; Hamishehkar, H.; Dolatabadi, J.E.N.; Arsalani, N. Nano graphene oxide: A novel carrier for oral delivery of flavonoids. Colloids Surf. B Biointerfaces, 2014, 123, 331-338.
[http://dx.doi.org/10.1016/j.colsurfb.2014.09.036] [PMID: 25282100]
[199]
Lee, X.J.; Lim, H.N.; Gowthaman, N.S.K.; Rahman, M.B.A.; Che Abdullah, C.A.; Muthoosamy, K. In-situ surface functionalization of superparamagnetic reduced graphene oxide – Fe3O4 nanocomposite via Ganoderma lucidum extract for targeted cancer therapy application. Appl. Surf. Sci., 2020, 512, 145738.
[http://dx.doi.org/10.1016/j.apsusc.2020.145738]
[200]
Huang, C.; Chen, T.; Zhu, D.; Huang, Q. Enhanced tumor targeting and radiotherapy by quercetin loaded biomimetic nanoparticles. Front Chem., 2020, 8, 225.
[http://dx.doi.org/10.3389/fchem.2020.00225] [PMID: 32296682]
[201]
Liu, M.; Fu, M.; Yang, X.; Jia, G.; Shi, X.; Ji, J.; Liu, X.; Zhai, G. Paclitaxel and quercetin co-loaded functional mesoporous silica nanoparticles overcoming multidrug resistance in breast cancer. Colloids Surf. B Biointerfaces, 2020, 196, 111284.
[http://dx.doi.org/10.1016/j.colsurfb.2020.111284] [PMID: 32771817]
[202]
Mittal, A.K.; Kumar, S.; Banerjee, U.C. Quercetin and gallic acid mediated synthesis of bimetallic (silver and selenium) nanoparticles and their antitumor and antimicrobial potential. J. Colloid Interface Sci., 2014, 431, 194-199.
[http://dx.doi.org/10.1016/j.jcis.2014.06.030] [PMID: 25000181]
[203]
Lou, M.; Zhang, L.; Ji, P.; Feng, F.; Liu, J.; Yang, C.; Li, B.; Wang, L. Quercetin nanoparticles induced autophagy and apoptosis through AKT/ERK/Caspase-3 signaling pathway in human neuroglioma cells: In vitro and in vivo. Biomed. Pharmacother., 2016, 84, 1-9.
[http://dx.doi.org/10.1016/j.biopha.2016.08.055] [PMID: 27621033]
[204]
Patra, M.; Mukherjee, R.; Banik, M.; Dutta, D.; Begum, N.A.; Basu, T. Calcium phosphate-quercetin nanocomposite (CPQN): A multi-functional nanoparticle having pH indicating, highly fluorescent and anti-oxidant properties. Colloids Surf. B Biointerfaces, 2017, 154, 63-73.
[http://dx.doi.org/10.1016/j.colsurfb.2017.03.018] [PMID: 28324689]
[205]
Ren, K.W.; Li, Y.H.; Wu, G.; Ren, J.Z.; Lu, H.B.; Li, Z.M.; Han, X.W. Quercetin nanoparticles display antitumor activity via proliferation inhibition and apoptosis induction in liver cancer cells. Int. J. Oncol., 2017, 50(4), 1299-1311.
[http://dx.doi.org/10.3892/ijo.2017.3886] [PMID: 28259895]
[206]
Zhang, Z.; Xu, S.; Wang, Y.; Yu, Y.; Li, F.; Zhu, H.; Shen, Y.; Huang, S.; Guo, S. Near-infrared triggered co-delivery of doxorubicin and quercetin by using gold nanocages with tetradecanol to maximize anti-tumor effects on MCF-7/ADR cells. J. Colloid Interface Sci., 2018, 509, 47-57.
[http://dx.doi.org/10.1016/j.jcis.2017.08.097] [PMID: 28881205]
[207]
George, D.; Maheswari, P.U.; Begum, K.M.M.S. Synergic formulation of onion peel quercetin loaded chitosan-cellulose hydrogel with green zinc oxide nanoparticles towards controlled release, biocompatibility, antimicrobial and anticancer activity. Int. J. Biol. Macromol., 2019, 132, 784-794.
[http://dx.doi.org/10.1016/j.ijbiomac.2019.04.008] [PMID: 30951778]
[208]
Lakshmi, B.A.; Kim, S. Quercetin mediated gold nanoclusters explored as a dual functional nanomaterial in anticancer and bio-imaging disciplines. Colloids Surf. B Biointerfaces, 2019, 178, 230-237.
[http://dx.doi.org/10.1016/j.colsurfb.2019.02.054] [PMID: 30870790]
[209]
Maghsoodloo, S.; Ebrahimzadeh, M.A.; Tavakoli, S.; Mohammadi, H.; Biparva, P.; Rafiei, A. Green synthesis of multifunctional silver nanoparticles using quercetin and their therapeutic potential. J. Nanomed. Res., 2020, 5(2), 171-181.
[210]
Naderi, E.; Aghajanzadeh, M.; Zamani, M.; Hashiri, A.; Sharafi, A.; Kamalianfar, A.; Naseri, M.; Danafar, H. Improving the anti-cancer activity of quercetin-loaded AgFeO2 through UV irradiation: Synthesis, characterization, and in vivo and in vitro biocompatibility study. J. Drug Deliv. Sci. Technol., 2020, 57, 101645.
[http://dx.doi.org/10.1016/j.jddst.2020.101645]
[211]
Sun, X.; Li, Y.; Xu, L.; Shi, X.; Xu, M.; Tao, X.; Yang, G. Heparin coated meta-organic framework co-delivering doxorubicin and quercetin for effective chemotherapy of lung carcinoma. J. Int. Med. Res., 2020, 48(2)
[http://dx.doi.org/10.1177/0300060519897185] [PMID: 32054349]
[212]
Sadalage, P.S.; Patil, R.V.; Havaldar, D.V.; Gavade, S.S.; Santos, A.C.; Pawar, K.D. Optimally biosynthesized, PEGylated gold nanoparticles functionalized with quercetin and camptothecin enhance potential anti-inflammatory, anti-cancer and anti-angiogenic activities. J. Nanobiotechnology, 2021, 19(1), 84.
[http://dx.doi.org/10.1186/s12951-021-00836-1] [PMID: 33766058]
[213]
Thakur, N.S.; Mandal, N.; Patel, G.; Kirar, S.; Reddy, Y.N.; Kushwah, V.; Jain, S.; Kalia, Y.N.; Bhaumik, J.; Banerjee, U.C. Co-administration of zinc phthalocyanine and quercetin via hybrid nanoparticles for augmented photodynamic therapy. Nanomedicine, 2021, 33, 102368.
[http://dx.doi.org/10.1016/j.nano.2021.102368] [PMID: 33548477]
[214]
Minaei, A.; Sabzichi, M.; Ramezani, F.; Hamishehkar, H.; Samadi, N. Co-delivery with nano-quercetin enhances doxorubicin-mediated cytotoxicity against MCF-7 cells. Mol. Biol. Rep., 2016, 43(2), 99-105.
[http://dx.doi.org/10.1007/s11033-016-3942-x] [PMID: 26748999]
[215]
Han, Q.; Yang, R.; Li, J.; Liang, W.; Zhang, Y.; Dong, M.; Besenbacher, F.; Wang, C. Enhancement of biological activities of nanostructured hydrophobic drug species. Nanoscale, 2012, 4(6), 2078-2082.
[http://dx.doi.org/10.1039/c2nr12013e] [PMID: 22331105]
[216]
Lockhart, J.N.; Stevens, D.M.; Beezer, D.B.; Kravitz, A.; Harth, E. Dual drug delivery of tamoxifen and quercetin: Regulated metabolism for anticancer treatment with nanosponges. J. Control. Release, 2015, 220(Pt B), 751-757.
[http://dx.doi.org/10.1016/j.jconrel.2015.08.052] [PMID: 26344396]

Rights & Permissions Print Cite
Article Metrics
50
2
Wayfinder Image
© 2024 Bentham Science Publishers | Privacy Policy